Using a Telehealth Model to Address Vaccine Hesitancy and Increase Vaccine Completion Among Communities in Southeastern Louisiana

项目总结/摘要-项目3 药剂师在大流行中的作用得到了扩大，他们既是一线工作者， 在检测和疫苗接种工作以及一线和远程医疗的临床医生中， 能力。远程医疗模式对所有疫苗接种的影响，目标是COVID-19 疫苗接种，在疫苗犹豫和疫苗耐药的个人是未知的 在健康不平等的社区中。本提案的目的是评估 一个药剂师主导的远程医疗干预模式，嵌入在一个一般的健康和健康 在服务水平低下的高风险社区开展COVID-19和流感疫苗接种的模型。的 中心假设是，根据我们正在进行的研究的初步数据， 从事高风险行业的个人，如美容、食品、运输、酒店、护理/ 医疗辅助人员和工厂工人，他们都受到COVID-19的不成比例的影响， 接受COVID-19疫苗和流感疫苗的可能性较小。此外，一个建立 药剂师领导的远程医疗模式，在更大的健康和 健康模式将增加疫苗接种，特别是COVID-19疫苗接种。的 中心假设将通过以下方式进行检验：1）通过接种表评估疫苗犹豫， 符合条件的参与者，2）实施个体化随机分组治疗试验方法 参与者将被随机分配到对照组（远程健康）和干预组， （包括健康和疫苗接种教育的远程保健）。主要成果将 是COVID-19疫苗接种与流感疫苗接种的次要结局， 疫苗犹豫这项拟议中的研究意义重大，因为它将确定 药剂师的有效性，他们被认为是最容易获得的医疗保健 专业人员和远程保健增加疫苗接种。预期的结果是， 干预组的疫苗接受率提高了15%。结果将有一个 在经历疫苗差异的社区中产生积极影响，并将有助于告知其他人 卫生保健专业人员如何将疫苗教育纳入目前的远程保健访问。 这一项目将为将一个经过检验的疫苗教育模式纳入 可提供给获得护理机会减少的高风险个人的远程保健模式 以及增加感染COVID-19和其他疫苗可预防疾病（如流感）的风险。它 也将影响药剂师的作用，因为干预模式将通过 泽维尔的继续教育努力，以准备药剂师为他们不断扩大的作用 作为疫苗大使

PROJECT SUMMARY / ABSTRACT – PROJECT 3 The expanded role of pharmacists in the pandemic was demonstrated as both frontline workers in testing and vaccination efforts and clinicians both on the frontline and in remote, telehealth capacities. The impact of a telehealth model on all vaccine uptake, with a target of COVID-19 vaccine uptake, among vaccine hesitant and vaccine resistant individuals is yet unknown among health disparity communities. The objective of this proposal to assess the effectiveness of a pharmacist led telehealth intervention model, embedded in a general health and wellness model on COVID-19 and influenza vaccine uptake in underserved, high risk communities. The central hypothesis is that, based upon our preliminary data from on our ongoing research, that individuals in high risk industries such as beauty, food, transportation, hospitality, nursing/ medical aids and plant workers, all of whom were disproportionately impacted by COVID-19, are less likely to accept a COVID-19 vaccine and influenza vaccines. Also, an established pharmacist led telehealth model that delivers a vaccine education in a larger health and wellness model will increase vaccine uptake, specifically COVID-19 vaccine uptake. The central hypothesis will be tested by 1) assessing vaccine hesitancy via an intake form among eligible participants, 2) implementing an individualized randomized group treatment trial approach where participants will be randomized to the control (telehealth wellness) vs the intervention (telehealth with wellness and vaccination education) over two years. The primary outcome will be COVID-19 vaccine uptake with a secondary outcome of influenza vaccines uptake and vaccine hesitancy. The proposed research is significant because it will determine the effectiveness of pharmacists, who are considered among the most accessible healthcare professionals, and telehealth on increasing vaccinations. The expected outcomes are there will be a 15% increase in vaccine acceptance in the intervention group. The results will have a positive impact in communities that experience vaccine disparities and will serve to inform other healthcare professionals on how to incorporate vaccine education in current telehealth visits. This project will lay the groundwork for a tested vaccine education model to be incorporated in telehealth models that can be delivered to high-risk individuals with decreased access to care and increased risk for COVID-19 and other vaccine preventable diseases, such as influenza. It will also impact the role of pharmacists as the intervention model will be offered through Xavier’s continuing education efforts to prepare pharmacists for their continuing expanding role as vaccine ambassadors.